JP2017503867A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503867A5 JP2017503867A5 JP2016566857A JP2016566857A JP2017503867A5 JP 2017503867 A5 JP2017503867 A5 JP 2017503867A5 JP 2016566857 A JP2016566857 A JP 2016566857A JP 2016566857 A JP2016566857 A JP 2016566857A JP 2017503867 A5 JP2017503867 A5 JP 2017503867A5
- Authority
- JP
- Japan
- Prior art keywords
- fluoro
- ethenopyrazolo
- methyl
- tetrahydro
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931506P | 2014-01-24 | 2014-01-24 | |
| US61/931,506 | 2014-01-24 | ||
| US201462049326P | 2014-09-11 | 2014-09-11 | |
| US62/049,326 | 2014-09-11 | ||
| US201562106301P | 2015-01-22 | 2015-01-22 | |
| US62/106,301 | 2015-01-22 | ||
| PCT/US2015/012597 WO2015112806A2 (en) | 2014-01-24 | 2015-01-23 | Diaryl macrocycles as modulators of protein kinases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019034652A Division JP2019104748A (ja) | 2014-01-24 | 2019-02-27 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017503867A JP2017503867A (ja) | 2017-02-02 |
| JP2017503867A5 true JP2017503867A5 (enExample) | 2018-03-08 |
| JP6490713B2 JP6490713B2 (ja) | 2019-03-27 |
Family
ID=53682127
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016566857A Active JP6490713B2 (ja) | 2014-01-24 | 2015-01-23 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
| JP2019034652A Withdrawn JP2019104748A (ja) | 2014-01-24 | 2019-02-27 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
| JP2021001588A Pending JP2021063121A (ja) | 2014-01-24 | 2021-01-07 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
| JP2022110613A Active JP7356546B2 (ja) | 2014-01-24 | 2022-07-08 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
| JP2023158350A Ceased JP2023179539A (ja) | 2014-01-24 | 2023-09-22 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019034652A Withdrawn JP2019104748A (ja) | 2014-01-24 | 2019-02-27 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
| JP2021001588A Pending JP2021063121A (ja) | 2014-01-24 | 2021-01-07 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
| JP2022110613A Active JP7356546B2 (ja) | 2014-01-24 | 2022-07-08 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
| JP2023158350A Ceased JP2023179539A (ja) | 2014-01-24 | 2023-09-22 | タンパク質キナーゼのモジュレータとしてのジアリール大環状化合物 |
Country Status (35)
Families Citing this family (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2350075T1 (sl) | 2008-09-22 | 2014-06-30 | Array Biopharma, Inc. | Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji |
| BRPI0919873B8 (pt) | 2008-10-22 | 2021-05-25 | Array Biopharma Inc | compostos de pirazol[1,5-a]pirimidina substituídos como inibidores da trk quinase, seus processos de preparação e composições farmacêuticas |
| AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| SMT201700372T1 (it) | 2010-05-20 | 2017-09-07 | Array Biopharma Inc | Composti macrociclici come inibitori di trk chinasi |
| RS59059B1 (sr) | 2014-01-24 | 2019-08-30 | Turning Point Therapeutics Inc | Diaril makrociklična jedinjenja kao modulatori protein kinaza |
| CA2967951C (en) | 2014-11-16 | 2023-11-07 | Array Biopharma, Inc. | Crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate |
| US10758525B2 (en) | 2015-01-22 | 2020-09-01 | MyoKardia, Inc. | 4-methylsulfonyl-substituted piperidine urea compounds |
| EP3722441A1 (en) | 2015-06-01 | 2020-10-14 | Loxo Oncology Inc. | Method of diagnosing a cancer for a treatment with a trk inhibitor |
| CN107735399B (zh) * | 2015-07-02 | 2021-01-26 | 特普医药公司 | 作为蛋白质激酶的调节剂的手性二芳基大环 |
| PL3319969T3 (pl) * | 2015-07-06 | 2024-06-24 | Turning Point Therapeutics, Inc. | Diarylowe polimorfy makrocykliczne |
| HRP20210177T1 (hr) | 2015-07-16 | 2021-03-19 | Array Biopharma, Inc. | Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze |
| RU2020123800A (ru) | 2015-07-21 | 2020-10-02 | Тёрнинг Поинт Терапьютикс, Инк. | Хиральные диарильные макроциклы и их применение |
| EP3368039A1 (en) | 2015-10-26 | 2018-09-05 | The Regents of The University of Colorado, A Body Corporate | Point mutations in trk inhibitor-resistant cancer and methods relating to the same |
| WO2017106505A1 (en) * | 2015-12-15 | 2017-06-22 | University Of South Florida | Gas5 binding compounds, formulations, and uses thereof |
| BR112018070017A2 (pt) | 2016-04-04 | 2019-02-05 | Loxo Oncology Inc | métodos de tratamento de cânceres pediátricos |
| US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
| PT3439662T (pt) | 2016-04-04 | 2024-09-30 | Loxo Oncology Inc | Formulações líquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida |
| PT3458456T (pt) | 2016-05-18 | 2020-12-07 | Array Biopharma Inc | Preparação de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidino-1-carboxamida |
| AU2017302019A1 (en) | 2016-07-28 | 2019-02-07 | Turning Point Therapeutics, Inc. | Macrocycle kinase inhibitors |
| TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
| JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
| JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
| CN110267960B (zh) | 2017-01-18 | 2022-04-26 | 阿雷生物药品公司 | 作为RET激酶抑制剂的取代的吡唑并[1,5-a]吡嗪化合物 |
| WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
| TWI808958B (zh) * | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
| JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
| CN107586796B (zh) * | 2017-07-20 | 2021-08-06 | 暨明医药科技（苏州）有限公司 | (r)-2-(1-氨基乙基)-4-氟苯酚的合成方法 |
| KR102645316B1 (ko) | 2017-07-28 | 2024-03-07 | 터닝 포인트 테라퓨틱스, 인크. | 거대환형 화합물 및 이의 용도 |
| TWI876442B (zh) | 2017-10-10 | 2025-03-11 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
| TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
| CA3080157A1 (en) | 2017-10-26 | 2019-05-02 | Array Biopharma Inc. | Formulations of a macrocyclic trk kinase inhibitor |
| CN109516999B (zh) * | 2017-11-01 | 2021-08-17 | 郑州泰基鸿诺医药股份有限公司 | 用作蛋白质激酶调节剂的化合物及其应用 |
| US11098046B2 (en) | 2017-11-10 | 2021-08-24 | Angex Pharmaceutical, Inc. | Macrocyclic compounds as TRK kinase inhibitors and uses thereof |
| WO2019126122A1 (en) | 2017-12-19 | 2019-06-27 | Tp Therapeutics, Inc. | Macrocyclic kinase inhibitors and their use |
| JP7194188B2 (ja) * | 2017-12-19 | 2022-12-21 | ターニング・ポイント・セラピューティクス・インコーポレイテッド | 疾患を治療するための大環状化合物 |
| JP7150356B2 (ja) * | 2017-12-22 | 2022-10-11 | 深▲チェン▼市塔吉瑞生物医薬有限公司 | 置換ピラゾロ［１，５－ａ］ピリミジン化合物並びにその医薬組成物および使用 |
| CA3087972C (en) | 2018-01-18 | 2023-01-10 | Array Biopharma Inc. | Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors |
| CN111630054B (zh) | 2018-01-18 | 2023-05-09 | 奥瑞生物药品公司 | 作为RET激酶抑制剂的取代的吡唑并[3,4-d]嘧啶化合物 |
| CN111971286B (zh) | 2018-01-18 | 2023-04-14 | 阿雷生物药品公司 | 作为RET激酶抑制剂的取代的吡咯并[2,3-d]嘧啶化合物 |
| EP3744723B1 (en) | 2018-01-23 | 2023-10-18 | Shenzhen TargetRx, Inc. | Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound |
| WO2019149131A1 (zh) * | 2018-01-30 | 2019-08-08 | 上海吉倍生物技术有限公司 | 具有大环分子结构的化合物及其用途 |
| CN110156813B (zh) * | 2018-02-13 | 2023-07-25 | 北京诺诚健华医药科技有限公司 | 作为trk抑制剂的杂环化合物 |
| KR20200141041A (ko) * | 2018-03-28 | 2020-12-17 | 포천 파마슈티컬즈, 엘티디. | Trk 키나제 억제제로서의 마크로사이클릭 화합물 |
| WO2019191659A1 (en) | 2018-03-29 | 2019-10-03 | Loxo Oncology, Inc. | Treatment of trk-associated cancers |
| CN110386944B (zh) * | 2018-04-16 | 2021-10-29 | 深圳市塔吉瑞生物医药有限公司 | 用于抑制蛋白激酶活性的二(杂)芳基大环化合物 |
| ES2989075T3 (es) * | 2018-04-25 | 2024-11-25 | Primegene Beijing Co Ltd | Compuesto macrocíclico diarílico y composición farmacéutica y uso del mismo |
| CN111918868B (zh) * | 2018-05-04 | 2022-12-30 | 正大天晴药业集团股份有限公司 | 作为蛋白激酶调节剂的二芳基大环化合物 |
| CN110627812B (zh) | 2018-06-25 | 2022-10-11 | 北京诺诚健华医药科技有限公司 | 作为trk抑制剂的杂环化合物 |
| KR102612513B1 (ko) | 2018-07-31 | 2023-12-12 | 록쏘 온콜로지, 인코포레이티드 | (s)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1h-피라졸-4-카르복스아미드의 분무-건조된 분산물 및 제제 |
| US11964988B2 (en) | 2018-09-10 | 2024-04-23 | Array Biopharma Inc. | Fused heterocyclic compounds as RET kinase inhibitors |
| CN110950889B (zh) * | 2018-09-27 | 2022-04-05 | 北京赛林泰医药技术有限公司 | 一种多靶点激酶抑制剂及其制备方法和用途 |
| US20210403485A1 (en) * | 2018-09-29 | 2021-12-30 | Shandong Luye Pharmaceutical Co., Ltd. | Pyrazolopyrimidine derivative as selective trk inhibitor |
| CA3117200A1 (en) | 2018-10-22 | 2020-04-30 | Esker Therapeutics, Inc. | Tyk2 inhibitors and uses thereof |
| KR20210088675A (ko) * | 2018-11-09 | 2021-07-14 | 산동 수안주 파마 코포레이션 리미티드 | 마크로사이클릭 타이로신 키나아제 억제제 및 그 용도 |
| CN111171049B (zh) * | 2018-11-09 | 2021-06-04 | 山东轩竹医药科技有限公司 | 酪氨酸激酶抑制剂及其用途 |
| CA3119638A1 (en) * | 2018-11-19 | 2020-05-28 | Dana-Farber Cancer Institute, Inc. | Macrocyclic inhibitors of dyrk1a |
| JP2022515198A (ja) | 2018-12-19 | 2022-02-17 | アレイ バイオファーマ インコーポレイテッド | ＦＧＦＲチロシンキナーゼの阻害剤としての置換ピラゾロ［１，５－ａ］ピリジン化合物 |
| WO2020131674A1 (en) | 2018-12-19 | 2020-06-25 | Array Biopharma Inc. | 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer |
| CN111592541B (zh) * | 2019-02-21 | 2021-09-10 | 山东轩竹医药科技有限公司 | 大环类激酶抑制剂及其用途 |
| IL286248B2 (en) * | 2019-03-11 | 2025-12-01 | Alumis Inc | Tyk2 inhibitors and uses thereof |
| EA202192625A1 (ru) * | 2019-03-26 | 2022-03-21 | Вентикс Байосайенсес, Инк. | Лиганды псевдокиназы tyk2 |
| EP3974434B1 (en) * | 2019-05-21 | 2025-11-19 | Zhejiang Hisun Pharmaceutical Co., Ltd. | Macrolide derivatives, preparation method and application thereof |
| JP2022537385A (ja) * | 2019-06-19 | 2022-08-25 | ターニング・ポイント・セラピューティクス・インコーポレイテッド | 大環状キナーゼ阻害剤の多形 |
| WO2020257189A1 (en) * | 2019-06-19 | 2020-12-24 | Turning Point Therapeutics, Inc. | Macrocycles for treating disease |
| WO2020257165A1 (en) * | 2019-06-19 | 2020-12-24 | Turning Point Therapeutics, Inc. | Macrocycles for use in treating disease |
| CN112110938B (zh) * | 2019-06-21 | 2021-11-09 | 成都海博为药业有限公司 | 一种作为蛋白质激酶抑制剂的化合物及其制备方法和用途 |
| MA56505A (fr) * | 2019-06-21 | 2022-04-27 | Janssen Pharmaceutica Nv | Inhibiteurs macrocycliques de mcl-1 |
| JP2022540678A (ja) | 2019-07-16 | 2022-09-16 | マイオカーディア，インク | （ｒ）－４－（１－（（３－（ジフルオロメチル）－１－メチル－１ｈ－ピラゾール－４－イル）スルホニル）－１－フルオロエチル）－ｎ－（イソキサゾール－３－イル）ピペリジン－１－カルボキシアミドの多形体 |
| WO2021027503A1 (zh) * | 2019-08-12 | 2021-02-18 | 罗欣药业(上海)有限公司 | 三环类化合物、其制备方法、中间体及应用 |
| CN114423762B (zh) * | 2019-09-30 | 2024-03-29 | 浙江海正药业股份有限公司 | 大环类衍生物及其制备方法和用途 |
| IL293208A (en) | 2019-11-27 | 2022-07-01 | Turning Point Therapeutics Inc | Combination therapy involving diaryl macrocyclic compounds |
| CA3162632A1 (en) | 2019-11-27 | 2021-06-03 | Turning Point Therapeutics, Inc. | Combination therapy involving diaryl macrocyclic compounds |
| JP7641965B2 (ja) | 2019-12-03 | 2025-03-07 | ターニング・ポイント・セラピューティクス・インコーポレイテッド | 疾患処置に使用するための大環状分子 |
| US20230101747A1 (en) | 2019-12-06 | 2023-03-30 | Schrödinger, Inc. | Cyclic compounds and methods of using same |
| BR112022012684A2 (pt) | 2019-12-27 | 2023-03-07 | Schroedinger Inc | Compostos cíclicos e métodos de uso dos mesmos |
| CN113045587A (zh) * | 2019-12-27 | 2021-06-29 | 成都倍特药业股份有限公司 | 一种大环结构化合物的晶型及其制备方法 |
| CN113135938B (zh) * | 2020-01-19 | 2022-06-14 | 山东轩竹医药科技有限公司 | 取代的大环类酪氨酸激酶抑制剂及其用途 |
| EP4114530A4 (en) * | 2020-03-02 | 2024-04-17 | Turning Point Therapeutics, Inc. | THERAPEUTIC USES OF MACROCYCLIC COMPOUNDS |
| EP4146220A4 (en) | 2020-05-04 | 2024-05-29 | Amgen Inc. | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTORS EXPRESSED ON MYELOID CELL 2 AGONISTS AND METHODS OF USE |
| KR20230008767A (ko) * | 2020-05-08 | 2023-01-16 | 산동 수안주 파마 코포레이션 리미티드 | 거대고리형 티로신 키나제 억제제의 결정형 및 그의 제조 방법 |
| CN113754682B (zh) * | 2020-06-04 | 2023-01-06 | 赛诺哈勃药业（成都）有限公司 | 具有大环结构的化合物及其用途 |
| WO2022011123A1 (en) * | 2020-07-10 | 2022-01-13 | Blossomhill Therapeutics, Inc. | Macrocycles and their use |
| US20230365584A1 (en) | 2020-09-10 | 2023-11-16 | Schrödinger, Inc. | Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancer |
| EP4284804A1 (en) | 2021-01-26 | 2023-12-06 | Schrödinger, Inc. | Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders |
| WO2022182845A1 (en) * | 2021-02-25 | 2022-09-01 | Blossomhill Therapeutics, Inc. | Macrocycles and their use |
| TW202300150A (zh) | 2021-03-18 | 2023-01-01 | 美商薛定諤公司 | 環狀化合物及其使用方法 |
| CN113754657B (zh) * | 2021-09-22 | 2023-01-17 | 广州白云山医药集团股份有限公司白云山制药总厂 | 大环类化合物的晶型及其制备方法和应用 |
| CN116063326B (zh) * | 2021-11-02 | 2025-08-05 | 赛诺哈勃药业（成都）有限公司 | 作为蛋白激酶调节剂的含氨基大环化合物 |
| CN116514813A (zh) * | 2021-12-31 | 2023-08-01 | 轩竹生物科技股份有限公司 | 酪氨酸激酶抑制剂及其中间体的制备方法 |
| CA3246487A1 (en) * | 2022-01-05 | 2023-07-13 | Blossomhill Therapeutics, Inc. | MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS |
| CN115746023B (zh) * | 2022-10-27 | 2024-08-09 | 复旦大学 | 一种作为蛋白激酶抑制剂的含吲唑结构的杂环大环化合物及其制备方法 |
| WO2025059027A1 (en) | 2023-09-11 | 2025-03-20 | Schrödinger, Inc. | Cyclopenta[e]pyrazolo[1,5-a]pyrimidine derivatives as malt1 inhibitors |
| WO2025217347A2 (en) | 2024-04-11 | 2025-10-16 | Bristol-Myers Squibb Company | Process of preparing repotrectinib |
| WO2025235733A1 (en) * | 2024-05-09 | 2025-11-13 | Blossomhill Therapeutics, Inc. | Bis-bicycloheteroaryl macrocycles and their use |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4838925A (en) | 1986-04-25 | 1989-06-13 | E. I. Du Pont De Nemours And Company | Heterocyclic acyl sulfonamides |
| ES2021105B3 (es) | 1987-03-07 | 1991-10-16 | Bayer Ag | Procedimiento para la obtencion de 5-amino-4,6-dihalogeno piridinas. |
| DE69425736T2 (de) | 1993-03-25 | 2001-04-12 | Pharmacia & Upjohn Co., Kalamazoo | Formyl- oder Cyano- substituierte Indolderivate mit dopaminergischer Wirkung |
| CZ291950B6 (cs) | 1993-12-07 | 2003-06-18 | Eli Lilly And Company | Bis-indolmaleinimidy, jako inhibitory proteinové kinázy C, léčivo, farmaceutický prostředek s jejich obsahem a jejich použití |
| FR2746309B1 (fr) | 1996-03-22 | 1998-04-17 | Oreal | Composition de teinture des fibres keratiniques contenant des pyrazolopyrimidineoxo ; leur utilisation pour la teinture comme coupleurs, procedes de teinture |
| RS49779B (sr) | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| FR2793791B1 (fr) | 1999-05-19 | 2002-01-25 | Univ Paris 7 Denis Diderot | Nouveaux composes inhibiteurs specifiques de phospholipases a2 |
| AU2001283955B2 (en) | 2000-07-31 | 2006-05-18 | F. Hoffmann-La Roche Ag | Piperazine derivatives |
| AU2002227371B2 (en) | 2000-12-08 | 2007-05-10 | Ortho-Mcneil Pharmaceutical, Inc. | Macroheterocylic compounds useful as kinase inhibitors |
| AU2002254114A1 (en) | 2001-03-23 | 2002-10-08 | Eli Lilly And Company | Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| WO2004052315A2 (en) | 2002-12-11 | 2004-06-24 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US7970766B1 (en) | 2007-07-23 | 2011-06-28 | Google Inc. | Entity type assignment |
| ES2668834T3 (es) | 2008-09-08 | 2018-05-22 | Merck Serono Sa | Pirimidinas macrociclicas como inhibidores de proteína quinasas |
| SI2350075T1 (sl) | 2008-09-22 | 2014-06-30 | Array Biopharma, Inc. | Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji |
| BRPI0919873B8 (pt) | 2008-10-22 | 2021-05-25 | Array Biopharma Inc | compostos de pirazol[1,5-a]pirimidina substituídos como inibidores da trk quinase, seus processos de preparação e composições farmacêuticas |
| MX2011004494A (es) | 2008-10-31 | 2011-05-24 | Genentech Inc | Compuestos de pirazolopirimidina inhibidores de jak y metodos. |
| WO2010063487A1 (en) | 2008-12-05 | 2010-06-10 | Merz Pharma Gmbh & Co. Kgaa | Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| WO2010086040A1 (en) | 2009-01-29 | 2010-08-05 | Biomarin Iga, Ltd. | Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy |
| AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| US20110029480A1 (en) * | 2009-08-03 | 2011-02-03 | IntelliCubes, Inc. | Method of Compiling Multiple Data Sources into One Dataset |
| KR20120087916A (ko) | 2009-10-13 | 2012-08-07 | 엘랑코 애니멀 헬쓰 아일랜드 리미티드 | 마크로시클릭 인테그라제 억제제 |
| WO2011071716A1 (en) | 2009-12-07 | 2011-06-16 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds containing an indole core |
| JP5643332B2 (ja) | 2009-12-07 | 2014-12-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ピロロピリジンまたはベンゾイミダゾールコアを含有する複素環化合物 |
| SA111320200B1 (ar) | 2010-02-17 | 2014-02-16 | ديبيوفارم اس ايه | مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة |
| SMT201700372T1 (it) | 2010-05-20 | 2017-09-07 | Array Biopharma Inc | Composti macrociclici come inibitori di trk chinasi |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
| WO2012075393A2 (en) | 2010-12-02 | 2012-06-07 | President And Fellows Of Harvard College | Activators of proteasomal degradation and uses thereof |
| EP2508607A1 (en) * | 2011-04-07 | 2012-10-10 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for liver regeneration and for treatment of liver failure |
| WO2013001310A1 (en) | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
| WO2013028470A1 (en) | 2011-08-19 | 2013-02-28 | Merck Sharp & Dohme Corp. | Process and intermediates for preparing macrolactams |
| WO2013045701A2 (en) | 2011-09-29 | 2013-04-04 | L'oreal | Dyeing process using a composition comprising a glycosyl iridoid compound and a nucleophile or an amino or thio polymer, composition and devices therefor |
| WO2013045702A2 (en) | 2011-09-29 | 2013-04-04 | L'oreal | Dye composition comprising a non-glycosyl iridoid compound and a specific nucleophile or an amino or thio polymer, dyeing process, and device therefor |
| HUE027318T2 (en) * | 2011-09-30 | 2016-10-28 | Oncodesign Sa | Macrocyclic FLT3 kinase inhibitors |
| GB2495134B (en) | 2011-09-30 | 2014-06-11 | Tridonic Uk Ltd | Power supply apparatus |
| JP6073343B2 (ja) | 2011-10-20 | 2017-02-01 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | サーチュイン調節因子としての置換された二環式アザ複素環およびアナログ |
| CN104169286B (zh) | 2012-03-06 | 2016-06-08 | 辉瑞大药厂 | 用于治疗增殖性疾病的大环衍生物 |
| BR112014022000A8 (pt) | 2012-03-09 | 2021-06-15 | Lexicon Pharmaceuticals Inc | compostos à base de pirazol[1,5-a]pirimidina, seu uso e composições que os compreende |
| EP2822559B1 (en) * | 2012-03-09 | 2018-05-02 | Lexicon Pharmaceuticals, Inc. | Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and uses thereof |
| EP2645540A1 (de) | 2012-03-28 | 2013-10-02 | Siemens Aktiengesellschaft | Glimmschutzwerkstoff für eine elektrische Maschine |
| GB201205669D0 (en) | 2012-03-30 | 2012-05-16 | Agency Science Tech & Res | Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof |
| WO2014118186A1 (en) | 2013-01-30 | 2014-08-07 | Bayer Pharma Aktiengesellschaft | Amino-substituted isothiazoles |
| EP2989082A1 (en) | 2013-04-23 | 2016-03-02 | LEK Pharmaceuticals d.d. | Novel synthetic process to 8-chloro-1-methyl-benzo[d]azepine, novel intermediates and the production thereof |
| JPWO2015012328A1 (ja) | 2013-07-24 | 2017-03-02 | 武田薬品工業株式会社 | 複素環化合物 |
| WO2015073267A1 (en) | 2013-11-15 | 2015-05-21 | Calitor Sciences, Llc | Substituted heteroaryl compounds and methods of use |
| RS59059B1 (sr) | 2014-01-24 | 2019-08-30 | Turning Point Therapeutics Inc | Diaril makrociklična jedinjenja kao modulatori protein kinaza |
| WO2016070241A1 (en) | 2014-11-03 | 2016-05-12 | Ctxt Pty Ltd | Triazine compounds, compositions and synthesis |
| HUE067779T2 (hu) | 2014-12-15 | 2024-11-28 | Cmg Pharmaceutical Co Ltd | Kondenzált gyûrûs heteroaril vegyületek és azok felhasználása TRK inhibitorokként |
| US9981944B2 (en) | 2015-02-20 | 2018-05-29 | Rigel Pharmaceuticals, Inc | GDF-8 inhibitors |
| EP3267996B1 (en) | 2015-03-12 | 2020-11-11 | Merck Sharp & Dohme Corp. | Pyrazolopyrimidine inhibitors of irak4 activity |
| US10155765B2 (en) | 2015-03-12 | 2018-12-18 | Merck Sharp & Dohme Corp. | Carboxamide inhibitors of IRAK4 activity |
| CA2984848A1 (en) | 2015-05-05 | 2016-11-10 | Bayer Pharma Aktiengesellschaft | Amido-substituted cyclohexane derivatives |
| CN108289610A (zh) | 2015-06-29 | 2018-07-17 | Q-科雷医疗有限公司 | 用于感测和分析医疗装置的导管内的流体和其中的气泡的特性的方法、电路、装置、组件、系统和相关联的计算机可执行代码 |
| CN107735399B (zh) | 2015-07-02 | 2021-01-26 | 特普医药公司 | 作为蛋白质激酶的调节剂的手性二芳基大环 |
| PL3319969T3 (pl) | 2015-07-06 | 2024-06-24 | Turning Point Therapeutics, Inc. | Diarylowe polimorfy makrocykliczne |
| RU2020123800A (ru) | 2015-07-21 | 2020-10-02 | Тёрнинг Поинт Терапьютикс, Инк. | Хиральные диарильные макроциклы и их применение |
| EP3368039A1 (en) | 2015-10-26 | 2018-09-05 | The Regents of The University of Colorado, A Body Corporate | Point mutations in trk inhibitor-resistant cancer and methods relating to the same |
| EP3423435B1 (en) | 2016-03-04 | 2023-08-23 | Vanderbilt University | Substituted indole mcl-1 inhibitors |
| AU2017302019A1 (en) | 2016-07-28 | 2019-02-07 | Turning Point Therapeutics, Inc. | Macrocycle kinase inhibitors |
| JP2020533269A (ja) | 2016-12-14 | 2020-11-19 | デベロップメント センター フォー バイオテクノロジー | 抗体−薬物複合体およびその使用 |
| TWI808958B (zh) | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
| KR102645316B1 (ko) | 2017-07-28 | 2024-03-07 | 터닝 포인트 테라퓨틱스, 인크. | 거대환형 화합물 및 이의 용도 |
-
2015
- 2015-01-23 RS RS20190900A patent/RS59059B1/sr unknown
- 2015-01-23 RS RS20221161A patent/RS63829B1/sr unknown
- 2015-01-23 WO PCT/US2015/012597 patent/WO2015112806A2/en not_active Ceased
- 2015-01-23 PT PT15740510T patent/PT3097107T/pt unknown
- 2015-01-23 NZ NZ722375A patent/NZ722375A/en unknown
- 2015-01-23 DK DK19169041.1T patent/DK3572416T3/da active
- 2015-01-23 HU HUE19212110A patent/HUE066590T2/hu unknown
- 2015-01-23 SM SM20240175T patent/SMT202400175T1/it unknown
- 2015-01-23 EA EA201892241A patent/EA201892241A1/ru unknown
- 2015-01-23 JP JP2016566857A patent/JP6490713B2/ja active Active
- 2015-01-23 EP EP19212106.9A patent/EP3636648A1/en not_active Withdrawn
- 2015-01-23 DK DK15740510.1T patent/DK3097107T3/da active
- 2015-01-23 EA EA201691492A patent/EA031863B1/ru active IP Right Revival
- 2015-01-23 SM SM20190388T patent/SMT201900388T1/it unknown
- 2015-01-23 PL PL15740510T patent/PL3097107T3/pl unknown
- 2015-01-23 EP EP19212126.7A patent/EP3636650A1/en not_active Withdrawn
- 2015-01-23 PE PE2016000959A patent/PE20160931A1/es unknown
- 2015-01-23 SG SG11201605929RA patent/SG11201605929RA/en unknown
- 2015-01-23 DK DK19212110.1T patent/DK3636649T3/da active
- 2015-01-23 ES ES19169041T patent/ES2933350T3/es active Active
- 2015-01-23 RS RS20240447A patent/RS65417B1/sr unknown
- 2015-01-23 ES ES19212110T patent/ES2976459T3/es active Active
- 2015-01-23 HU HUE19169041A patent/HUE060554T2/hu unknown
- 2015-01-23 PT PT191690411T patent/PT3572416T/pt unknown
- 2015-01-23 LT LTEP19212110.1T patent/LT3636649T/lt unknown
- 2015-01-23 LT LTEP15740510.1T patent/LT3097107T/lt unknown
- 2015-01-23 FI FIEP19212110.1T patent/FI3636649T3/fi active
- 2015-01-23 LT LTEP19169041.1T patent/LT3572416T/lt unknown
- 2015-01-23 EP EP15740510.1A patent/EP3097107B1/en active Active
- 2015-01-23 CN CN201910549014.1A patent/CN110317213B/zh active Active
- 2015-01-23 HU HUE15740510A patent/HUE045208T2/hu unknown
- 2015-01-23 CN CN201580005705.5A patent/CN106170289B/zh active Active
- 2015-01-23 PT PT192121101T patent/PT3636649T/pt unknown
- 2015-01-23 EP EP19169041.1A patent/EP3572416B1/en active Active
- 2015-01-23 US US15/113,583 patent/US9714258B2/en not_active Ceased
- 2015-01-23 CA CA2936079A patent/CA2936079C/en active Active
- 2015-01-23 SI SI201531994T patent/SI3636649T1/sl unknown
- 2015-01-23 HR HRP20221518TT patent/HRP20221518T1/hr unknown
- 2015-01-23 SI SI201531908T patent/SI3572416T1/sl unknown
- 2015-01-23 KR KR1020167020188A patent/KR102402179B1/ko active Active
- 2015-01-23 EP EP19212110.1A patent/EP3636649B1/en active Active
- 2015-01-23 SI SI201530810T patent/SI3097107T1/sl unknown
- 2015-01-23 MY MYPI2016001385A patent/MY193524A/en unknown
- 2015-01-23 SM SM20230008T patent/SMT202300008T1/it unknown
- 2015-01-23 ES ES15740510T patent/ES2735729T3/es active Active
- 2015-01-23 US US18/147,888 patent/USRE50634E1/en active Active
- 2015-01-23 NZ NZ761094A patent/NZ761094A/en unknown
- 2015-01-23 MX MX2020001360A patent/MX392904B/es unknown
- 2015-01-23 SG SG10202000191YA patent/SG10202000191YA/en unknown
- 2015-01-23 HR HRP20191283TT patent/HRP20191283T1/hr unknown
- 2015-01-23 CN CN201910549748.XA patent/CN110317214B/zh active Active
- 2015-01-23 HR HRP20240503TT patent/HRP20240503T1/hr unknown
- 2015-01-23 UA UAA201608991A patent/UA121206C2/uk unknown
- 2015-01-23 MX MX2016009588A patent/MX2016009588A/es active IP Right Grant
- 2015-01-23 PL PL19212110.1T patent/PL3636649T3/pl unknown
- 2015-01-23 AP AP2016009383A patent/AP2016009383A0/en unknown
- 2015-01-23 PL PL19169041.1T patent/PL3572416T3/pl unknown
- 2015-01-23 EP EP23220719.1A patent/EP4338739A3/en active Pending
-
2016
- 2016-07-07 ZA ZA2016/04654A patent/ZA201604654B/en unknown
- 2016-07-20 IL IL246860A patent/IL246860B/en active IP Right Grant
- 2016-07-22 CL CL2016001876A patent/CL2016001876A1/es unknown
- 2016-07-25 PH PH12016501463A patent/PH12016501463A1/en unknown
-
2017
- 2017-05-31 US US15/609,962 patent/US10246466B2/en active Active
-
2018
- 2018-11-29 US US16/204,566 patent/US10618912B2/en active Active
-
2019
- 2019-02-27 JP JP2019034652A patent/JP2019104748A/ja not_active Withdrawn
- 2019-07-17 CY CY20191100764T patent/CY1121850T1/el unknown
- 2019-08-21 IL IL268820A patent/IL268820B/en unknown
- 2019-12-10 AU AU2019279951A patent/AU2019279951B2/en active Active
-
2020
- 2020-02-21 US US16/797,866 patent/US20200216465A1/en not_active Abandoned
- 2020-07-06 ZA ZA2020/04100A patent/ZA202004100B/en unknown
-
2021
- 2021-01-07 JP JP2021001588A patent/JP2021063121A/ja active Pending
- 2021-09-27 US US17/485,942 patent/US20220112213A1/en not_active Abandoned
-
2022
- 2022-07-08 JP JP2022110613A patent/JP7356546B2/ja active Active
-
2023
- 2023-07-28 US US18/227,561 patent/US12404281B2/en active Active
- 2023-09-22 JP JP2023158350A patent/JP2023179539A/ja not_active Ceased
-
2025
- 2025-03-12 NL NL301322C patent/NL301322I2/nl unknown
- 2025-03-13 NO NO2025015C patent/NO2025015I1/no unknown
- 2025-03-20 HU HUS2500016C patent/HUS2500016I1/hu unknown
- 2025-03-20 FI FIC20250015C patent/FIC20250015I1/fi unknown
- 2025-04-08 LT LTPA2025513C patent/LTPA2025513I1/lt unknown
- 2025-04-09 FR FR25C1013C patent/FR25C1013I2/fr active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017503867A5 (enExample) | ||
| HRP20191283T1 (hr) | Diaril makrocikli kao modulatori protein kinaze | |
| RU2370496C2 (ru) | Конденсированные производные пиридина, применимые в качестве антагонистов аденозинового рецептора a2b | |
| JP2018522869A5 (enExample) | ||
| HRP20211864T1 (hr) | Inhibitori hetero-halo histonske deacetilaze | |
| AP762A (en) | Substituted 6,5-hetero-bicyclic derivatives. | |
| RU2015131148A (ru) | СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ | |
| JP2016504363A5 (enExample) | ||
| JP2016523270A5 (enExample) | ||
| HRP20190748T1 (hr) | Derivati policikličkog amida kao inhibitori cdk9 | |
| JP2014513139A5 (enExample) | ||
| NZ586579A (en) | Fused heterocyclic derivatives and methods of use as c-met inhibitors | |
| JP2001097889A (ja) | Ｃｒｆアンタゴニストおよび関連組成物の使用 | |
| JP2014533734A5 (enExample) | ||
| JOP20190144A1 (ar) | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز | |
| TN2016000271A1 (en) | Heteroaryl substituted nicotinamide compounds. | |
| RU2007107910A (ru) | Гетероциклические соединения | |
| JP2018501315A5 (enExample) | ||
| HRP20170349T1 (hr) | Novi derivati pirola, postupak njihove priprave i farmaceutski pripravci koji ih sadrže | |
| RU2014115478A (ru) | Новые гетероциклические производные и их применения | |
| JP2011500774A5 (enExample) | ||
| RU2014115227A (ru) | Производные бензотиазол-6-ил уксусной кислоты и их примение для лечения вич-инфекции | |
| JP2012515205A5 (enExample) | ||
| RU2016111675A (ru) | Соединения биарилацетамида и способы их применения | |
| RU2015148189A (ru) | ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1 |